United-Guardian Inc

UGConsumer Defensive·Household & Personal Products·USA·Nano·NASD·Nov 12 • 3:59 PM ET

8.63+0.04 (0.47%)

2026-11-12 22:20 CET

Market cap

$39.65M

Revenue, TTM

12.44 USD m

Net income, TTM

3.13 USD m

Free cash flow, TTM

- USD m

EPS diluted, TTM

0.68

Price / earnings

12.68

Compare

Price

UG against its 20, 50 and 200-day averages

Terms2050200

Patternshover a marker to name it

13.3% under the 52-week high of 9.95 on 10 Nov 2026. 52-week low 5.58 on 25 Nov 2025. Last 15 sessions, 50.8% high to low

Volume 1.60× normal · the line is the 50-bar volume average

Setup. RS line 6
CANSLIM 1 of 6 — fails: 52-Week High/Low: 0-10% below High; Performance: Year +50%; Institutional Ownership: Over 50%; Average Volume: Over 200K — not on the tape: EPS Growth This Year: High (>25%)
VCP 3 of 6 — fails: 52-Week High/Low: 0-10% below High; RSI (14): Not Overbought (<60); Relative Volume: Under 1
Minervini 2 of 4 — fails: 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 4 of 5 — fails: 20-Day High/Low: 0-5% below High
Leaders 2 of 5 — fails: Performance: Year +50%; Average Volume: Over 500K; 52-Week High/Low: 0-10% below High
Breakout 2 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2
Growth 2 of 4 — not on the tape: EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%)
Quality 5 of 5
Value 3 of 4 — fails: P/B: Under 2
Income 2 of 4 — fails: Dividend Growth: Growing 2+ Years; Payout Ratio: Low (<20%)
Small Cap 2 of 4 — fails: Average Volume: Over 500K; Performance: Year +50%
Accumulation 2 of 4 — fails: Institutional Ownership: Over 30%; Institutional Transactions: Over +10%
Relative Strength 1 of 3 — fails: Performance: Year +100%; Average Volume: Over 500K

Profile

52-week range, 70% of the way up

5.589.95

United-Guardian, Inc. engages in the development and manufacture of pharmaceuticals, cosmetic ingredients, personal and health care products and medical devices. It also conducts research and product development related to the development of new and unique cosmetic and personal care products. The company was founded by Alfred R. Globus in 1942 and is headquartered in Hauppauge, NY.

Employees	25
IPO	Mar 17, 1980
Beta	1.00
ATR, 14d	0.54
Rel volume	1.60
Short float	0.29%
Insider own	35.65%
Inst own	19.20%

Snapshot

6 groups

Valuation

Index	-
Market Cap	$39.65M
Enterprise Value	30.06M
Income	3.13M
Sales	12.44M
Book / share	2.53
Cash / share	2.09
Dividend Est.	-
Dividend TTM	0.55 (6.37%)
Dividend Ex-Date	Jul 28, 2026
Dividend Gr. 3/5Y	-4.09% -5.11%
Payout	130.92%
Employees	25
IPO	Mar 17, 1980

Ratios

Price / earnings	12.68
Forward price / earnings	-
Price / earnings / growth	-
Price / sales	3.19
Price / book	3.41
Price / cash	4.13
Price / free cash flow	11.66
Value / cash profit	12.27
Value / sales	2.42
Quick Ratio	6.64
Current Ratio	7.32
Debt / equity	0.00
Long-term debt / equity	0.00
Options and short	No / Yes

Earnings

Earnings / share	0.68
Earnings next year	-
Earnings next quarter	-
Earnings this year	-
Earnings next year	-
Earnings growth, 5 years	-
Past earnings growth	-6.42% -8.62%
Past sales growth	-6.01% -0.82%
Earnings vs last year	59.59%
Sales vs last year	23.63%
Earnings vs last quarter	246.92%
Sales vs last quarter	54.35%
Earnings	-
Surprise	- -

Ownership

Insiders own	35.65%
Insider trades	0.00%
Institutions own	19.20%
Institution trades	-0.40%
Return on assets	18.27%
Return on equity	21.35%
Return on capital	26.89%
Gross Margin	50.14%
Operating margin	25.95%
Profit Margin	25.15%
20-day average	19.79%
50-day average	20.77%
200-day average	23.14%

Technical

Shares out	4.59M
Shares floating	2.96M
Short / float	0.29%
Short ratio	0.68
Short interest	0.01M
52-week high	9.95 -13.3%
52-week low	5.58 +54.8%
Volatility	9.60% 5.50%
Average range	0.54
Strength index	68.27
Market sensitivity	1.00
Relative volume	1.60
Avg Volume	12.77K
Volume	20,385

Performance

Perf Week	26.91%
Perf Month	23.82%
Perf Quarter	20.70%
Perf Half Y	20.36%
Perf YTD	40.10%
Perf Year	40.55%
Perf 3Y	21.65%
Perf 5Y	-39.20%
Perf 10Y	-44.90%
Recommendation	-
Target Price	-
Prev Close	8.59
Price	8.63
Change %	0.47%

Peers

Mkt cap

Ticker	Company	Mkt cap
SLSN	Solesence Inc	64.22M
SKIN	SkinHealth Systems Inc	104.41M
ACU	Acme United Corp	278.62M
ASH	Ashland Inc	3.45B
IOSP	Innospec Inc	1.95B
SXT	Sensient Technologies Corp	4.94B
LFCR	Lifecore Biomedical Inc	242.60M
BCPC	Balchem Corp	5.48B
PBH	Prestige Consumer Healthcare Inc	2.15B
NTIC	Northern Technologies International Corp	73.60M

Ticker

Company

Mkt cap

SLSN

Solesence Inc

64.22M

SKIN

SkinHealth Systems Inc

104.41M

ACU

Acme United Corp

278.62M

ASH

Ashland Inc

3.45B

IOSP

Innospec Inc

1.95B

SXT

Sensient Technologies Corp

4.94B

LFCR

Lifecore Biomedical Inc

242.60M

BCPC

Balchem Corp

5.48B

PBH

Prestige Consumer Healthcare Inc

2.15B

NTIC

Northern Technologies International Corp

73.60M

Held by

AUM

Ticker	Company	AUM
VTI	Vanguard Morningstar Total Stock Market ETF	AUM: 696.31B
DFMC	U.S. Micro Cap Portfolio ETF Class Shares	AUM: 213.58M
VXF	Vanguard Extended Market Index ETF	AUM: 30.79B
DFAS	U.S. Small Cap Portfolio-ETF Class Shares	AUM: 15.64B
IWC	iShares Micro-Cap ETF	AUM: 1.23B
BUSM	EA Bridgeway Ultra-Small Company Market ETF	AUM: 112.81M
DFAC	U.S. Core Equity 2 Portfolio-ETF Class Shares	AUM: 49.67B
DCOR	US Core Equity 1 Portfolio ETF Class Shares	AUM: 3.69B
DFSU	Dimensional US Sustainability Core 1 ETF	AUM: 2.40B
DXUV	US Vector Equity Portfolio ETF Class Shares	AUM: 671.26M

Ticker

Company

AUM

VTI

Vanguard Morningstar Total Stock Market ETF

AUM: 696.31B

DFMC

U.S. Micro Cap Portfolio ETF Class Shares

AUM: 213.58M

VXF

Vanguard Extended Market Index ETF

AUM: 30.79B

DFAS

U.S. Small Cap Portfolio-ETF Class Shares

AUM: 15.64B

IWC

iShares Micro-Cap ETF

AUM: 1.23B

BUSM

EA Bridgeway Ultra-Small Company Market ETF

AUM: 112.81M

DFAC

U.S. Core Equity 2 Portfolio-ETF Class Shares

AUM: 49.67B

DCOR

US Core Equity 1 Portfolio ETF Class Shares

AUM: 3.69B

DFSU

Dimensional US Sustainability Core 1 ETF

AUM: 2.40B

DXUV

US Vector Equity Portfolio ETF Class Shares

AUM: 671.26M

News

latest 14 of 200

Nov-09-26 09:07AMUnited-Guardian: Q3 Earnings Snapshot (Associated Press) +31.89%
09:00AMUnited-Guardian Reports Higher Third Quarter Earnings (GlobeNewswire)
Aug-07-26 10:47AMUnited-Guardian: Q2 Earnings Snapshot (Associated Press)
10:30AMUnited-Guardian Reports Second Quarter Results (GlobeNewswire)
Jul-16-26 09:00AMUnited-Guardian Declares Cash Dividend (GlobeNewswire)
May-08-26 09:03AMUnited-Guardian: Q1 Earnings Snapshot (Associated Press)
09:00AMUnited-Guardian Reports First Quarter Results (GlobeNewswire)
Mar-27-26 09:33AMUnited-Guardian: Q4 Earnings Snapshot (Associated Press Finance)
09:00AMUnited-Guardian Reports 2025 Financial Results (GlobeNewswire)
Jan-29-26 09:00AMUnited-Guardian Declares Cash Dividend (GlobeNewswire) +9.04%
Dec-12-25 04:31PMTop Analyst Reports for Visa, Charles Schwab & Amphenol (Zacks)
Nov-11-25 02:04PMUG Q3 Profit Falls Y/Y on Weak Cosmetics Sales, Stock Declines 10% (Zacks)
Nov-06-25 09:07AMUnited-Guardian: Q3 Earnings Snapshot (Associated Press Finance) -6.29%
09:00AMUnited-Guardian Reports Third Quarter Earnings (GlobeNewswire)

Key figures

Revenue, TTM	12.44
Net income, TTM	3.13
EPS diluted, TTM	0.68
EBIT, TTM	3.23
Free cash flow, TTM	-
Gross margin	50.14%
Operating margin	25.95%
Net margin	25.15%
Market cap, statement	39.47
Price / earnings	12.68
Sales Y/Y, TTM	23.63%

USD millions. TTM from the statement feed.

Quarterly earnings

actual against estimate

Period	Reported	EPS act	EPS est	EPS rep	Sales act	Sales est	Analysts
2026Q1	2026-05-08	-	-	0.178	2.87	-	-
2025Q3	2025-11-06	-	-	0.058	2.26	-	-
2025Q2	2025-08-08	-	-	0.136	2.84	-	-
2025Q1	2025-05-08	-	-	0.122	2.48	-	-
2024Q3	2024-11-08	-	-	0.188	3.06	-	-
2024Q2	2024-08-09	-	-	0.208	3.39	-	-
2024Q1	2024-05-10	-	-	0.201	3.25	-	-
2023Q3	2023-11-06	-	-	0.136	3.06	-	-
2023Q2	2023-08-11	-	-	0.100	2.65	-	-
2023Q1	2023-05-11	-	-	0.165	2.57	-	-
2022Q3	2022-11-09	-	-	0.075	2.42	-	-
2022Q2	2022-08-12	-	-	0.138	3.63	-	-
2022Q1	2022-05-12	-	-	0.198	3.89	-	-
2021Q3	2021-11-10	-	-	0.221	3.18	-	-
2021Q2	2021-08-11	-	-	0.293	3.66	-	-
2021Q1	2021-05-12	-	-	0.257	3.43	-	-

Annual earnings

Period	EPS act	EPS est	EPS rep	Sales act	Sales est
2010FY	0.800	-	0.800	13.72	-
2011FY	1.030	0.930	1.030	14.34	-
2012FY	1.050	-	1.050	13.83	-
2013FY	1.280	-	1.280	15.42	-

Estimate revisions

last 14 periods

Period	Type	Date	Estimates	Up	Down	Mean	Low	High
No estimate revisions.

Period

Type

Date

Estimates

Down

Mean

Low

High

No estimate revisions.

Estimate history

Period	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
EPS, annual	0.837	0.947	1.036	0.719	1.014	0.559	0.562	0.708	0.458	0.6808
EPS, quarterly	0.188	0.11	0.122	0.136	0.058	0.141	0.178	0.159	0.203
Period	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26	Q3 '26
Sales, annual	12.968	13.446	13.599	10.986	13.93	12.699	10.885	12.182	10.545	12.44
Period	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
Sales, quarterly	3.06	2.477	2.481	2.838	2.264	2.962	2.872	3.108	3.495
Period	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26	Q3 '26
Shares, annual	4.594	4.594	4.594	4.594	4.594	4.594	4.594	4.594	4.594	4.594
Period	2017	2018	2019	2020	2021	2022	2023	2024	2025	MRQ
Shares, quarterly	4.594	4.594	4.594	4.594	4.594	4.594	4.594	4.594	-
Period	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26	Q3 '26

Income statement, annual

Currency USD, millions
Metric	TTM	2025FY	2024FY	2023FY	2022FY	2021FY	2020FY	2019FY	2018FY
Total Revenue	12.44	10.55	12.18	10.89	12.70	13.93	10.99	13.60	13.45
Cost of Goods Sold Incl. D&A	6.20	5.51	5.72	5.48	6.00	5.75	4.87	5.66	5.34
Gross Profit	6.24	5.03	6.46	5.41	6.70	8.18	6.11	7.94	8.10
Selling, General and Administrative Excl. Other	2.92	2.79	2.81	2.54	2.66	2.51	2.48	2.55	2.52
Research and Development	0.45	0.36	0.46	0.46	0.49	0.48	0.45	0.40	0.40
Other Operating Expense	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Income	3.23	2.24	3.65	2.86	4.04	5.67	3.64	5.40	5.58
Interest Expense	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Unusual Expense	-	-0.04	-0.03	-0.51	0.68	0.13	0.12	-0.17	0.34
Net Income Before Taxes	3.94	2.64	4.11	3.25	3.23	5.88	4.16	6.03	5.47
Income Taxes	0.81	0.54	0.86	0.67	0.66	1.22	0.86	1.27	1.11
Consolidated Net Income	3.13	2.11	3.25	2.58	2.57	4.66	3.30	4.76	4.35
Net Income From Continuing Operations	3.13	2.11	3.25	2.58	2.57	4.66	3.30	4.76	4.35
Net Income	3.13	2.11	3.25	2.58	2.57	4.66	3.30	4.76	4.35
EPS (Recurring)	0.68	0.45	0.70	0.48	0.66	1.03	0.74	1.01	1.00
EPS (Basic, Before Extraordinaries)	0.68	0.46	0.71	0.56	0.56	1.01	0.72	1.04	0.95
EPS (Diluted)	0.68	0.46	0.71	0.56	0.56	1.01	0.72	1.04	0.95
EBITDA	-	2.35	3.74	2.97	4.17	5.81	3.80	5.57	5.77
Non-Operating Income (Expense)	0.38	0.36	0.43	-0.13	-0.13	0.35	0.64	0.47	0.22
Other After Tax Adjustments	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price To Earnings Ratio	12.62	12.62	12.60	13.11	15.95	16.22	19.99	18.96	19.44
Price To Sales Ratio	2.64	2.68	3.61	3.04	3.78	5.43	6.01	6.64	6.27
Gross Margin	50.14	47.73	53.03	49.66	52.78	58.74	55.65	58.40	60.26
Operating Margin	25.95	21.27	29.94	26.30	31.79	40.68	33.10	39.68	41.50
Net Margin	25.15	19.97	26.69	23.71	20.23	33.44	30.08	35.01	32.37
Shares Outstanding	-	4.59	4.59	4.59	4.59	4.59	4.59	4.59	4.59
Market Capitalization	39.47	39.47	43.92	33.08	47.96	75.57	66.05	90.27	84.26

Income statement, quarterly

Currency USD, millions
Metric	2026Q3	2026Q2	2026Q1	2025Q4	2025Q3	2025Q2	2025Q1	2024Q4
Total Revenue	3.49	3.11	2.87	2.96	2.26	2.84	2.48	2.48
Cost of Goods Sold Incl. D&A	1.62	1.56	1.45	1.66	1.34	1.34	1.12	1.20
Gross Profit	1.88	1.55	1.42	1.30	0.93	1.50	1.36	1.28
Selling, General and Administrative Excl. Other	0.77	0.79	0.78	0.58	0.71	0.80	0.75	0.73
Research and Development	0.12	0.12	0.12	0.09	0.09	0.11	0.11	0.13
Other Operating Expense	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Income	1.11	0.75	0.64	0.72	0.22	0.70	0.61	0.56
Interest Expense	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Unusual Expense	-	-0.08	-0.29	0.04	-0.04	-0.02	-0.01	0.05
Net Income Before Taxes	1.17	0.92	1.03	0.82	0.33	0.79	0.71	0.64
Income Taxes	0.24	0.19	0.21	0.17	0.06	0.16	0.15	0.14
Consolidated Net Income	0.93	0.73	0.82	0.65	0.27	0.63	0.56	0.50
Net Income From Continuing Operations	0.93	0.73	0.82	0.65	0.27	0.63	0.56	0.50
Net Income	0.93	0.73	0.82	0.65	0.27	0.63	0.56	0.50
EPS (Recurring)	0.20	0.15	0.13	0.15	0.05	0.13	0.12	0.12
EPS (Basic, Before Extraordinaries)	0.20	0.16	0.18	0.14	0.06	0.14	0.12	0.11
EPS (Diluted)	0.20	0.16	0.18	0.14	0.06	0.14	0.12	0.11
EBITDA	-	0.78	0.67	0.75	0.24	0.72	0.64	0.58
Non-Operating Income (Expense)	0.06	0.08	0.10	0.13	0.08	0.07	0.08	0.14
Other After Tax Adjustments	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price To Earnings Ratio	12.62	13.88	14.62	14.44	14.12	12.73	12.70	12.60
Price To Sales Ratio	2.64	2.93	2.81	2.68	3.59	3.39	3.62	3.61
Gross Margin	53.66	49.73	49.59	43.96	40.89	52.76	54.74	51.74
Operating Margin	31.73	24.26	22.37	24.37	9.50	24.50	24.62	22.46
Net Margin	26.64	23.44	28.51	21.93	11.86	22.09	22.61	20.34
Shares Outstanding	-	4.59	4.59	4.59	4.59	4.59	4.59	4.59
Market Capitalization	39.47	32.80	30.78	28.30	36.11	36.75	41.30	43.92

Balance sheet, annual

Currency USD, millions
Metric	2025FY	2024FY	2023FY	2022FY	2021FY	2020FY	2019FY	2018FY	2017FY
Cash & Short Term Investments	8.57	9.40	9.09	6.48	8.17	8.18	7.92	8.17	8.45
Short Term Receivables	1.59	1.43	1.57	1.43	1.81	1.39	2.10	1.67	1.91
Inventories	1.51	1.45	1.22	1.67	1.41	1.42	1.22	1.48	1.34
Other Current Assets	0.53	0.39	0.37	0.39	0.19	0.26	0.34	0.36	0.16
Total Current Assets	12.20	12.67	12.25	9.97	11.58	11.25	11.57	11.69	11.85
Net Property, Plant & Equipment	0.91	0.96	0.62	0.56	0.66	0.67	0.78	0.83	0.94
Total Investments and Advances	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intangible Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.35	0.61	0.49	0.50	0.44	0.30	0.26	0.26	0.17
Other Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.03	0.06
Total Assets	13.46	14.23	13.36	11.03	12.68	12.22	12.63	12.81	13.02
Short Term Debt Incl. Current Port. of LT Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable	0.48	0.43	0.13	0.03	0.41	0.03	0.07	0.19	0.35
Income Tax Payable	-	-	-	0.00	0.09	-	-	0.00	0.06
Other Current Liabilities	1.19	1.49	1.40	1.34	1.84	1.38	1.27	1.18	1.01
Total Current Liabilities	1.67	1.91	1.53	1.37	2.34	1.41	1.34	1.37	1.42
Long Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Provision for Risks Charges	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liabilities	0.56	0.44	0.44	0.39	0.52	0.45	0.65	0.52	0.21
Other Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	2.23	2.35	1.97	1.76	2.86	1.87	1.99	1.88	1.63
Non-Equity Reserves	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preferred Stock - Carrying Value	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Common Equity	11.23	11.88	11.39	9.27	9.82	10.35	10.63	10.92	11.40
Total Shareholders Equity	11.23	11.88	11.39	9.27	9.82	10.35	10.63	10.92	11.40
Accumulated Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity	11.23	11.88	11.39	9.27	9.82	10.35	10.63	10.92	11.40
Total Liabilities & Stockholders Equity	13.46	14.23	13.36	11.03	12.68	12.22	12.63	12.81	13.02
Book Value Per Share	2.44	2.59	2.48	2.02	2.14	2.25	2.31	2.38	2.48
Tangible Book Value Per Share	2.44	2.59	2.48	2.02	2.14	2.25	2.31	2.38	2.48
Full-Time Employees	25	25	25	24	24	25	28	29	31
Price to Book Ratio	3.39	3.86	3.11	4.79	7.70	6.38	8.49	7.71	5.70
Return on Assets	15.21	23.56	21.17	21.67	37.42	26.60	37.45	33.70	27.32
Return on Equity	18.22	27.94	24.99	26.92	46.18	31.50	44.18	39.00	30.49
Return on Invested Capital	18.75	27.36	22.67	27.73	47.43	31.92	44.78	39.84	33.73
Quick Ratio	6.41	5.86	7.19	6.04	4.35	6.95	7.71	7.47	7.39
Current Ratio	7.31	6.62	7.99	7.26	4.95	7.95	8.61	8.55	8.33

Cash flow, annual

Currency USD, millions
Metric	TTM	2025FY	2024FY	2023FY	2022FY	2021FY	2020FY	2019FY	2018FY
Net Income	-	2.11	3.25	2.58	2.57	4.66	3.30	4.76	4.35
Depreciation	-	0.11	0.10	0.11	0.14	0.15	0.17	0.18	0.19
Deferred Taxes & Investment Tax Credit	-	0.38	-0.12	0.06	-0.19	-0.07	-0.24	0.13	0.22
Other Funds (Non Cash)	-	-0.03	-0.04	-0.11	1.08	0.01	-0.31	-0.41	0.34
Funds from Operations	-	2.56	3.18	2.64	3.59	4.75	2.93	4.66	5.11
Extraordinary Item	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Changes in Working Capital	-	-0.60	0.29	0.51	-1.06	0.56	0.66	-0.18	-0.16
Income Taxes Payable	-	-	-	0.00	-0.09	0.09	-	0.00	-0.06
Cash from Operating Activities	-	1.97	3.47	3.14	2.53	5.31	3.59	4.48	4.95
Capital Expenditures	-	-0.06	-0.43	-0.17	-0.08	-0.12	-0.04	-0.11	-0.07
Net Assets From Acquisitions	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Sale of Fixed Assets and Businesses	-	0.00	0.00	0.01	0.04	0.00	0.00	0.00	0.00
Purchase or Sale of Investments	-	0.23	-6.64	4.88	0.94	-0.07	-0.43	1.19	-0.23
Purchase of Investments	-	-12.94	-8.46	-0.62	-1.93	-4.22	-6.80	-14.78	-8.26
Sale Or Maturity of Investments	-	13.18	1.81	5.51	2.87	4.15	6.37	15.96	8.02
Other Uses	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Sources	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash from Investing Activities	-	0.18	-7.08	4.73	0.90	-0.18	-0.47	1.07	-0.31
Cash Dividends Paid	-	-2.77	-2.76	-0.46	-3.12	-5.19	-3.58	-5.05	-4.82
Preferred Dividends (Cash Flow)	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Change in Capital Stock	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Repurchase of Common Pref Stock	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Sale of Common Pref Stock	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Proceedsfrom Stock Options	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Issuance or Reduction of Debt, Net	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Change in Long Term Debt	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Issuance of Long Term Debt	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Reduction of Long Term Debt	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Financing Active Other Cash Flow	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Financing Activities Uses	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash from Financing Activities	-	-2.77	-2.76	-0.46	-3.12	-5.19	-3.58	-5.05	-4.82
Net Change in Cash	-	-0.62	-6.37	7.41	0.30	-0.06	-0.46	0.50	-0.17
Free Cash Flow	-	1.91	3.03	2.98	2.45	5.20	3.55	4.36	4.88
Price to Free Cash Flow	-	-	158.68	13.13	-	10,953.12	-	-	1,423.31

Balance sheet, quarterly

Currency USD, millions
Metric	2026Q3	2026Q2	2026Q1	2025Q4	2025Q3	2025Q2
Cash & Short Term Investments	-	9.59	8.04	8.57	8.30	8.42
Short Term Receivables	-	1.69	2.01	1.59	1.16	1.91
Inventories	-	1.18	1.32	1.51	1.41	1.53
Other Current Assets	-	0.25	0.45	0.53	0.37	0.61
Total Current Assets	-	12.71	11.81	12.20	11.25	12.47
Net Property, Plant & Equipment	-	0.88	0.89	0.91	0.92	0.93
Total Investments and Advances	-	0.00	0.00	0.00	0.00	0.00
Intangible Assets	-	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	-	-	-	0.35	0.02	0.00
Other Assets	-	0.00	0.00	0.00	0.00	0.00
Total Assets	-	13.59	12.70	13.46	12.18	13.39
Short Term Debt Incl. Current Port. of LT Debt	-	0.00	0.00	0.00	0.00	0.00
Accounts Payable	-	0.50	0.11	0.48	0.24	0.42
Other Current Liabilities	-	1.24	1.35	1.19	1.35	1.44
Total Current Liabilities	-	1.74	1.47	1.67	1.60	1.85
Long Term Debt	-	0.00	0.00	0.00	0.00	0.00
Provision for Risks Charges	-	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liabilities	-	0.22	0.33	0.56	-	0.08
Other Liabilities	-	0.00	0.00	0.00	0.00	0.00
Total Liabilities	-	1.96	1.80	2.23	1.60	1.93
Non-Equity Reserves	-	0.00	0.00	0.00	0.00	0.00
Preferred Stock - Carrying Value	-	0.00	0.00	0.00	0.00	0.00
Common Equity	-	11.63	10.90	11.23	10.58	11.46
Total Shareholders Equity	-	11.63	10.90	11.23	10.58	11.46
Accumulated Minority Interest	-	0.00	0.00	0.00	0.00	0.00
Total Equity	-	11.63	10.90	11.23	10.58	11.46
Total Liabilities & Stockholders Equity	-	13.59	12.70	13.46	12.18	13.39
Book Value Per Share	-	2.53	2.37	2.44	2.30	2.49
Tangible Book Value Per Share	-	2.53	2.37	2.44	2.30	2.49
Full-Time Employees	-	-	-	25	-	-
Price to Book Ratio	-	3.01	2.74	2.67	3.15	3.39
Return on Assets	-	18.27	18.57	15.21	15.41	18.78
Return on Equity	-	21.35	21.75	18.22	17.85	21.68
Return on Invested Capital	-	6.26	7.51	5.78	2.54	5.47
Quick Ratio	-	6.64	7.15	6.41	6.16	5.90
Current Ratio	-	7.32	8.05	7.31	7.04	6.73

Cash flow, quarterly

Currency USD, millions
Metric	2026Q3	2026Q2	2026Q1	2025Q4	2025Q3	2025Q2
Net Income	-	0.73	0.82	0.65	0.27	0.63
Depreciation	-	0.03	0.03	0.03	0.03	0.03
Other Funds (Non Cash)	-	-0.06	-0.02	0.04	-0.04	-0.02
Funds from Operations	-	0.59	0.95	0.95	0.16	0.85
Extraordinary Item	-	0.00	0.00	0.00	0.00	0.00
Changes in Working Capital	-	0.93	-0.35	-0.62	0.86	-0.54
Cash from Operating Activities	-	1.52	0.60	0.33	1.01	0.30
Capital Expenditures	-	-0.02	-0.01	-0.02	-0.02	-0.02
Net Assets From Acquisitions	-	0.00	0.00	0.00	0.00	0.00
Sale of Fixed Assets and Businesses	-	0.01	0.00	0.00	0.00	0.00
Purchase or Sale of Investments	-	0.15	0.04	0.08	-0.75	0.22
Purchase of Investments	-	-0.54	-5.95	-0.80	-5.75	-0.93
Sale Or Maturity of Investments	-	0.69	5.99	0.88	4.99	1.15
Other Uses	-	0.00	0.00	0.00	0.00	0.00
Other Sources	-	0.00	0.00	0.00	0.00	0.00
Cash from Investing Activities	-	0.13	0.03	0.06	-0.77	0.21
Cash Dividends Paid	-	0.00	-1.15	0.00	-1.15	-0.01
Preferred Dividends (Cash Flow)	-	0.00	0.00	0.00	0.00	0.00
Change in Capital Stock	-	0.00	0.00	0.00	0.00	0.00
Repurchase of Common Pref Stock	-	0.00	0.00	0.00	0.00	0.00
Sale of Common Pref Stock	-	0.00	0.00	0.00	0.00	0.00
Proceedsfrom Stock Options	-	0.00	0.00	0.00	0.00	0.00
Issuance or Reduction of Debt, Net	-	0.00	0.00	0.00	0.00	0.00
Change in Long Term Debt	-	0.00	0.00	0.00	0.00	0.00
Issuance of Long Term Debt	-	0.00	0.00	0.00	0.00	0.00
Reduction of Long Term Debt	-	0.00	0.00	0.00	0.00	0.00
Net Financing Active Other Cash Flow	-	0.00	0.00	0.00	0.00	0.00
Other Financing Activities Uses	-	0.00	0.00	0.00	0.00	0.00
Cash from Financing Activities	-	0.00	-1.15	0.00	-1.15	-0.01
Net Change in Cash	-	1.65	-0.52	0.39	-0.91	0.50
Free Cash Flow	-	1.50	0.59	0.31	1.00	0.29
Price to Free Cash Flow	-	29.80	-	-	-	-

Revenue breakdown

Cosmetic Ingredients	2024: 5.44M 2025: 3.01M
Medical Lubricants	2024: 2.03M 2025: 2.11M
Pharmaceuticals	2024: 4.72M 2025: 5.43M
Non-US	2024: 2.01M 2025: 2.40M
United States	2024: 10.18M 2025: 8.14M

Short interest

shares short against float, oldest to newest

Settlement	Of float	Shares short	Float	Avg volume
2026-10-30	0.29%	0.0M	3.0M	9.22K
2026-10-15	0.26%	0.0M	3.0M	10.37K
2026-09-30	0.42%	0.0M	3.0M	8.80K
2026-09-15	0.67%	0.0M	3.0M	8.53K
2026-08-31	0.54%	0.0M	3.0M	7.90K
2026-08-14	0.39%	0.0M	3.0M	7.49K
2026-07-31	0.21%	0.0M	3.0M	7.28K
2026-07-15	0.31%	0.0M	3.0M	5.37K
2026-06-30	0.37%	0.0M	3.0M	5.04K
2026-06-15	0.25%	0.0M	3.0M	5.04K
2026-05-29	0.33%	0.0M	3.0M	4.60K
2026-05-15	0.33%	0.0M	3.0M	4.70K
2026-04-30	0.37%	0.0M	3.0M	6.58K
2026-04-15	0.43%	0.0M	3.0M	7.76K
2026-03-31	0.43%	0.0M	3.0M	8.35K
2026-03-13	0.27%	0.0M	3.0M	10.14K
2026-02-27	0.22%	0.0M	3.0M	11.45K
2026-02-13	0.25%	0.0M	3.0M	13.45K
2026-01-30	0.27%	0.0M	3.0M	12.12K
2026-01-15	0.23%	0.0M	3.0M	10.89K

Option chain

expiry 2026-11-12

Type	Strike	Bid	Ask	Last	IV	Open int	Volume	Delta	Theta	Vega
No option chain for this symbol.

Type

Strike

Bid

Ask

Last

Open int

Volume

Delta

Theta

Vega

No option chain for this symbol.

Latest SEC filings

Filed	Form	Description	Period	Link
2026-11-12	10-Q	Quarterly report pursuant to Section 13 or 15(d)	2026-09-30	SEC
2026-11-09	8-K	Current report	2026-11-09	SEC
2026-08-11	10-Q	Quarterly report pursuant to Section 13 or 15(d)	2026-06-30	SEC
2026-08-07	8-K	Current report	2026-08-07	SEC
2026-07-16	8-K	Current report	2026-07-16	SEC
2026-05-15	8-K	Current report	2026-05-13	SEC
2026-05-12	10-Q	Quarterly report pursuant to Section 13 or 15(d)	2026-03-31	SEC
2026-05-08	8-K	Current report	2026-05-08	SEC
2026-04-22	ARS	Annual report to security holders.	2025-12-31	SEC
2026-04-06	DEF 14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934	2026-05-13	SEC
2026-03-27	10-K	Annual report pursuant to Section 13 or 15(d)	2025-12-31	SEC
2026-03-27	8-K	Current report	2026-03-27	SEC
2026-01-29	8-K	Current report	2026-01-29	SEC
2026-01-23	4	Statement of changes in beneficial ownership of securities	2026-01-21	SEC
2025-11-06	10-Q	Quarterly report pursuant to Section 13 or 15(d)	2025-09-30	SEC
2025-11-06	8-K	Current report	2025-11-06	SEC
2025-08-08	10-Q	Quarterly report pursuant to Section 13 or 15(d)	2025-06-30	SEC
2025-08-08	8-K	Current report	2025-08-08	SEC
2025-07-15	8-K	Current report	2025-07-15	SEC
2025-05-21	8-K	Current report	2025-05-15	SEC
2025-05-16	8-K	Current report	2025-05-15	SEC
2025-05-13	10-Q	Quarterly report pursuant to Section 13 or 15(d)	2025-03-31	SEC
2025-05-08	8-K	Current report	2025-05-08	SEC
2025-04-15	ARS	Annual report to security holders.	2024-12-31	SEC
2025-04-07	DEF 14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934	2025-05-15	SEC
2025-03-21	10-K	Annual report pursuant to Section 13 or 15(d)	2024-12-31	SEC
2025-03-21	8-K	Current report	2025-03-21	SEC
2025-01-30	8-K	Current report	2025-01-30	SEC
2024-11-12	10-Q	Quarterly report pursuant to Section 13 or 15(d)	2024-09-30	SEC
2024-11-08	8-K	Current report	2024-11-08	SEC

Insider activity by month

Month	Bought	Buys	Sold	Sells
2026-11	0	0	0	0
2026-10	0	0	0	0
2026-09	0	0	0	0
2026-08	0	0	0	0
2026-07	0	0	0	0
2026-06	0	0	0	0
2026-05	0	0	0	0
2026-04	0	0	0	0
2026-03	0	0	0	0
2026-02	0	0	0	0
2026-01	0	0	0	0
2025-12	0	0	0	0
2025-11	0	0	0	0

Institutional holders

Manager	% owned
RENAISSANCE TECHNOLOGIES LLC	3.63%
GAMCO INVESTORS, INC. ET AL	3.58%
VANGUARD CAPITAL MANAGEMENT LLC	2.79%
DIMENSIONAL FUND ADVISORS LP	1.56%
Rodgers Brothers Inc.	1.30%
Teton Advisors, LLC	1.17%
PARTHENON LLC	1.10%
GABELLI FUNDS LLC	0.83%
GEODE CAPITAL MANAGEMENT, LLC	0.77%
UNITED CAPITAL FINANCIAL ADVISORS, LLC	0.44%

Funds

Fund	% owned
1290 VT GAMCO Small Company Value Portfolio	3.41%
VANGUARD TOTAL STOCK MARKET INDEX FUND	1.96%
TETON Westwood Mighty Mites Fund	1.17%
The Gabelli Small Cap Growth Fund	0.83%
VANGUARD EXTENDED MARKET INDEX FUND	0.78%
U.S. MICRO CAP PORTFOLIO	0.70%
Fidelity Extended Market Index Fund	0.37%
iShares Micro-Cap ETF	0.24%
Dimensional U.S. Small Cap ETF	0.23%
Ultra-Small Company Market Fund	0.18%

Dividends

per share

Ex date	Ordinary	Special
2026-07-28	0.3000	0.0000
2026-02-09	0.2500	0.0000
2025-07-25	0.2500	0.0000
2025-02-10	0.3500	0.0000
2024-07-23	0.3500	0.0000
2024-02-09	0.2500	0.0000
2023-07-25	0.1000	0.0000
2022-11-25	0.3100	0.0000
2022-05-20	0.3700	0.0000
2021-11-26	0.6500	0.0000
2021-05-27	0.4800	0.0000
2020-11-30	0.3600	0.0000
2020-06-02	0.4200	0.0000
2019-12-02	0.5500	0.0000
2019-05-30	0.5500	0.0000
2018-12-07	0.5500	0.0000
2018-05-29	0.5000	0.0000
2017-12-08	0.5000	0.5000
2017-05-25	0.4100	0.0100
2016-12-08	0.3900	0.0100

Period	Amount	Yield	Payout	Kind
2015FY	1.0000	5.22%	100%	paid
2016FY	0.7500	4.84%	133.5%	paid
2017FY	1.4200	7.68%	169.69%	paid
2018FY	1.0500	5.73%	110.84%	paid
2019FY	1.1000	5.60%	106.14%	paid
2020FY	0.7800	5.42%	108.42%	paid
2021FY	1.1300	6.87%	111.44%	paid
2022FY	0.6800	6.51%	121.58%	paid
2023FY	0.1000	1.39%	17.80%	paid
2024FY	0.6000	6.28%	84.79%	paid
2025FY	0.6000	9.74%	130.92%	paid

OakChart. UG. Cached 15 minutes. Terms

Some panels did not load: ratings, insider.